 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
August 11, 2020
Cancer Targeted Technology
The National Institutes of Health awarded $1.44 million to Seattle-based Cancer Targeted Technology to support its ongoing clinical trial of a new prostate cancer drug. The money makes up the second year of a three-year grant totaling $3.3 million. Cancer Targeted Technology is privately held.